SCHEMBL7299363

SCHEMBL7299363

N#Cc1ccc([O])c(C#N)c1C#N

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ UPP1 Q16831 1/20 0.34
▸ PGR P06401 1/20 0.32
▸ AR P10275 1/20 0.32
▸ TRPV4 Q9HBA0 2/20 0.31
▸ MCL1 Q07820 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ KDM4E B2RXH2 2/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ GAA P10253 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ VCAM1 P19320 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.30
▸ HIF1A Q16665 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ CACNA1B Q00975 1/20 0.30
▸ APBA1 Q02410 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL152358 0.84 TSHR (0.39) UPP1PGRARTRPV4MCL1
SCHEMBL31399295 0.84 TSHR (0.39) UPP1PGRARTRPV4MCL1
SCHEMBL3026903 0.78 CA1 (0.41) MCL1TSHRKDM4EMEN1ALDH1A1
SCHEMBL7295000 0.77 UPP1 (0.35) UPP1PGRARTRPV4MCL1
SCHEMBL7300758 0.76 PGR (0.31) PGRARKDM4EALDH1A1GAA
Acetonitrile SCHEMBL9498906 0.76 ALDH1A1 (0.40) UPP1PGRARTRPV4TSHR
SCHEMBL17570552 0.75 TSHR (0.46) PGRARTSHRKDM4EMEN1
Hexamethylbenzene SCHEMBL4271177 0.74 TSHR (0.44) PGRARTSHRKDM4EMEN1
SCHEMBL9843268 0.72 AR (0.33) UPP1PGRARTRPV4TSHR
SCHEMBL20690651 0.70 AR (0.42) UPP1PGRARTRPV4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5629406-A AMINO ACID DERIVATIVES SANKYO COMPANY, LIMITED (JP) 1997-05-13 — — US disclosed
EP-0587311-A1 Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1994-03-16 — — EP disclosed
Send feedback